A study on the mechanism of eravacycline resistance in carbapenem-resistant Acinetobacter baumannii in nosocomial infections

A study on the mechanism of eravacycline resistance in carbapenem-resistant Acinetobacter baumannii in nosocomial infections - Mechanism of eravacycline resistance in Acinetobacter baumannii

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400091350

Enrollment

Unknown

Registered

2024-10-28

Start date

2024-11-01

Completion date

Unknown

Last updated

2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nosocomial infections

Interventions

Carbapenem-resistant group:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Carbapenem-resistant Acinetobacter baumannii (CRAB) isolates separated from infectious samples of patients with nosocomial infection.

Exclusion criteria

Exclusion criteria: Carbapenem-resistant Acinetobacter baumannii (CRAB) isolates separated from infectious samples from patients with non-nosocomial infection (infection occurring within 48 hours of admission) will not be included in this study.

Design outcomes

Primary

Measure	Time frame
Antimicrobial susceptibility of Acinetobacter baumannii clinical isolates;Eravacycline susceptibility of Acinetobacter baumannii experimental isolates;	—

Countries

China

Contacts

Public ContactZhangjiangang

Beijing Hospital

zhangjiangang4950@bjhmoh.cn+86 188 1024 8789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026